Michael Cuffe - HCA Holdings Executive Vice President, Chief Clinical Officer
| HCA Etf | USD 333.52 0.00 0.00% |
Dr. Michael S. Cuffe M.D. is an President Physician Services Group of the Company. From October 2011 to January 2015, Dr. Cuffe also served as a Vice President of the Company. Prior to that time, Dr. Cuffe served Duke University Health System as Vice President for Ambulatory Services and Chief Medical Officer from March 2011 to October 2011 and Vice President Medical Affairs from June 2005 to March 2011. He also served Duke University School of Medicine as Vice Dean for Medical Affairs from June 2008 to March 2011, Deputy Chair of the Department of Medicine from August 2009 to August 2010 and Associate Professor of Medicine from March 2005 to October 2011. Prior that time, Dr. Cuffe served in various leadership roles with the Duke Clinical Research Institute, Duke University Medical Center and Duke University School of Medicine.
| Age | 55 |
| Tenure | 3 years |
| Professional Marks | Ph.D |
| Address | One Park Plaza, Nashville, TN, United States, 37203 |
| Phone | 615 344 9551 |
| Web | https://hcahealthcare.com |
Michael Cuffe Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Cuffe against HCA Holdings etf is an integral part of due diligence when investing in HCA Holdings. Michael Cuffe insider activity provides valuable insight into whether HCA Holdings is net buyers or sellers over its current business cycle. Note, HCA Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell HCA Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Cuffe over two months ago Disposition of 8358 shares by Michael Cuffe of HCA Holdings at 385.42 subject to Rule 16b-3 | ||
Michael Cuffe over six months ago Disposition of 4500 shares by Michael Cuffe of HCA Holdings subject to Rule 16b-3 | ||
Michael Cuffe over six months ago Disposition of 18660 shares by Michael Cuffe of HCA Holdings at 139.06 subject to Rule 16b-3 |
HCA Holdings Management Efficiency
The company has Return on Asset of 0.1139 % which means that on every $100 spent on assets, it made $0.1139 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.8244 %, implying that it generated $0.8244 on every 100 dollars invested. HCA Holdings' management efficiency ratios could be used to measure how well HCA Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Paola Arbour | Tenet Healthcare | 60 | |
| Atul Mathur | DaVita HealthCare Partners | N/A | |
| Frank Brown | Encompass Health Corp | N/A | |
| Jennifer Baldock | Surgery Partners | 53 | |
| Michael North | Amedisys | 59 | |
| Peter Mantegazza | Encompass Health Corp | N/A | |
| Christopher Howard | Acadia Healthcare | 57 | |
| Jim Gustafson | DaVita HealthCare Partners | N/A | |
| Kevin Reese | The Ensign Group | N/A | |
| Audrey Andrews | Tenet Healthcare | 53 | |
| John Hollinsworth | Acadia Healthcare | 61 | |
| Spencer Burton | The Ensign Group | 46 | |
| Douglas Coltharp | Encompass Health Corp | 62 | |
| Bradley Bickham | Addus HomeCare | 61 | |
| Bradley Owens | Surgery Partners | 54 | |
| Harrison Bane | Surgery Partners | 37 | |
| Bradley JD | Addus HomeCare | 62 | |
| Nick Muscato | Amedisys | 39 | |
| Thomas Arnst | Tenet Healthcare | 62 | |
| Benjamin Fordham | Community Health Systems | 67 | |
| Edmund Fay | Encompass Health Corp | 54 | |
Management Performance
| Return On Equity | 0.82 | ||||
| Return On Asset | 0.11 |
HCA Holdings Money Managers
| William Rutherford, Chief Financial Officer, Executive Vice President | ||
| Kathleen JD, Senior Officer | ||
| Andrea Smith, Independent Director | ||
| Christopher Wyatt, Senior Vice President Controller | ||
| Michael Cuffe, Executive Vice President, Chief Clinical Officer | ||
| William Frist, Independent Director | ||
| Jonathan Perlin, President - Clinical and Physician Services Group, Chief Medical Officer | ||
| J Morrow, Senior Vice President - Finance, Treasurer | ||
| Robert Waterman, Senior Vice President General Counsel, Chief Labor Relations Officer | ||
| Terence Arkel, Chief Division | ||
| Joseph Sowell, Senior Vice President Chief Development Officer | ||
| Charles Gressle, President Division | ||
| Dan Miller, President Division | ||
| Deborah Reiner, Senior Vice President of Marketing and Communications | ||
| Hugh Johnston, Independent Director | ||
| Timothy McManus, President Group | ||
| Arnold Moore, President - Service Line and Operations Integration | ||
| Jeff Cohen, Senior Vice President - Government Relations | ||
| Sammie Mosier, Senior Vice President Chief Nurse Executive | ||
| Paul Paslick, Senior Vice President, Chief Information Officer | ||
| Erol FACHE, President Group | ||
| Thomas Frist, Chairman of the Board | ||
| Michael Marks, Senior Finance | ||
| Charles Holliday, Independent Director | ||
| Jon Foster, President of American Group | ||
| Charles Hall, President of National Group | ||
| Wayne Riley, Independent Director | ||
| Samuel Hazen, Chief Executive Officer, Director | ||
| Greg Lowe, President Division | ||
| Michael Michelson, Independent Director | ||
| NancyAnn DeParle, Independent Director | ||
| Robert Dennis, Independent Director | ||
| Chad Wasserman, Senior Officer | ||
| Sandra Morgan, Senior Vice President — Provider Relations | ||
| MD Frist, Founder Emeritus | ||
| Jane Englebright, Senior Vice President and Chief Nursing Officer | ||
| Michael McAlevey, Senior Vice President and Chief Legal Officer | ||
| Martin Paslick, Senior Officer | ||
| Phillip Billington, Senior Vice President - Internal Audit Services | ||
| Kathryn Torres, Senior Vice President - Payer Contracting and Alignment | ||
| Jeffrey Cohen, Senior Relations | ||
| Kathleen Whalen, Senior Vice President Chief Ethics and Compliance Officer | ||
| MD MBA, Executive Officer | ||
| Frank CFA, Vice Relations | ||
| Joseph III, Senior Officer | ||
| Jim Brown, Chief Center | ||
| Brian Cook, President Division | ||
| Meg Crofton, Independent Director | ||
| Jennifer Berres, Chief Human Resource Officer, Senior Vice President |
HCA Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is HCA Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.82 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 124.59 B | ||||
| Shares Outstanding | 246.2 M | ||||
| Shares Owned By Insiders | 29.31 % | ||||
| Shares Owned By Institutions | 65.91 % | ||||
| Number Of Shares Shorted | 5.89 M | ||||
| Price To Earning | 13.57 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in HCA Etf
HCA Holdings financial ratios help investors to determine whether HCA Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HCA with respect to the benefits of owning HCA Holdings security.